Young Jo Kim

Title: Young Jo Kim: Innovator in Angiogenesis Inhibitor Purification

Introduction

Young Jo Kim is a notable inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of angiogenesis inhibitors. His work is crucial for developing treatments for various cancers and other medical conditions.

Latest Patents

Young Jo Kim holds a patent for the "Process of purifying angiogenesis inhibitors." This invention relates to the purification of angiogenesis inhibitor proteins expressed in recombinant kringle 1-3, also known as greenstatin. The process involves solubilizing, refolding, and purifying the proteins to achieve a pure and active form. The purified greenstatin specifically suppresses endothelial cell proliferation, angiogenesis, and the growth of lung cancer, skin cancer, and brain tumors. This innovative process is applicable for mass production of angiogenesis inhibitor proteins, which are beneficial for treating glaucoma, retinopathy, and various cancers.

Career Highlights

Young Jo Kim is currently associated with Korea Greencross Corporation, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, focusing on innovative solutions for critical health issues.

Collaborations

He collaborates with notable colleagues, including Weon Kyoo You and Seung Ho So, who contribute to his research endeavors and help drive forward the development of effective medical treatments.

Conclusion

Young Jo Kim's contributions to the field of angiogenesis inhibitors highlight the importance of innovation in biotechnology. His patented process not only advances scientific understanding but also offers potential solutions for serious health challenges.